Search Results - (Author, Cooperation:M. Slaoui)
-
1K. Famm ; B. Litt ; K. J. Tracey ; E. S. Boyden ; M. Slaoui
Nature Publishing Group (NPG)
Published 2013Staff ViewPublication Date: 2013-04-13Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: *Action Potentials/physiology ; Animals ; Drug Discovery ; Electric Stimulation Therapy/*methods/*trends ; Humans ; Interdisciplinary Communication ; *Neural Pathways/physiologyPublished by: -
2Slaoui, M. ; Urbain-Vansanten, G. ; Demeur, C. ; Leo, O. ; Marvel, J. ; Moser, M. ; Tassignon, J. ; Greene, M. I. ; Urbain, J.
Oxford, UK : Blackwell Publishing Ltd
Published 1986Staff ViewISSN: 1600-065XSource: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineType of Medium: Electronic ResourceURL: -
3URBAIN, J. ; FRANCOTTE, M. ; FRANSSEN, J. D. ; HIERNAUX, J. ; LEO, O. ; MOSER, M. ; SLAOUI, M. ; URBAIN-VANSANTEN, G. ; ACKER, A. ; WIKLER, M.
Oxford, UK : Blackwell Publishing Ltd
Published 1983Staff ViewISSN: 1749-6632Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: Natural Sciences in GeneralType of Medium: Electronic ResourceURL: -
4HIERNAUX, J. ; SLAOUI, M. ; LEO, O. ; MOSER, M. ; FRANSSEN, J.D. ; URBAIN, J.
Oxford, UK : Blackwell Publishing Ltd
Published 1983Staff ViewISSN: 1749-6632Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: Natural Sciences in GeneralType of Medium: Electronic ResourceURL: -
5Zepp, F. ; Schmitt, H.-J. ; Kaufhold, A. ; Schuind, A. ; Knuf, M. ; Habermehl, P. ; Meyer, C. ; Bogaerts, H. ; Slaoui, M. ; Clemens, R.
Springer
Published 1996Staff ViewISSN: 1432-1076Keywords: Key words Haemophilus influenzae type b ; Combination vaccine ; Immunological memorySource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract The lack of an adequate immune response to the major polysaccharide of the Haemophilus influenzae type b (Hib) capsule (polyribosyl ribitol phosphate) (PRP) in very young infants (〈 18 months) can be overcome by conjugating PRP to a T-cell dependent carrier protein. We studied whether administration of a tetanus-PRP conjugate vaccine reconstituted with a diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine as a three dose primary course at 3, 4 and 5 months of age induced PRP-specific immunological memory, by examining the anti-PRP response to a dose of unconjugated PRP given with the DTPa-HBV booster approximately 1 year later. The unconjugated PRP elicited protective anti-PRP antibody levels (≥ 0.15 μg/ml) in all but 3 of the 369 vaccinees, including 13 infants who failed to demonstrate a measurable immune response after the primary course. In a sub-cohort of 54 subjects all had anti-PRP levels ≥ 0.5 μg/ml within 7–14 days of the booster showing a rapid anamnestic type response. Both primary and booster responses were predominantly IgG1 indicating a T-cell dependent response. The DTPa-HBV components elicited protective anti-diphtheria, anti-tetanus and anti-HBs antibody levels in ≥ 98.5% of vaccinees, and immune responses to each of the acellular pertussis vaccine components in 92.3%–97.3% of subjects. Conclusion The tetanus-PRP conjugate vaccine not only elicited a good primary humoral response, but also induced immunological memory so that the infants were able to mount a large and rapid immune response to subsequent exposure to plain PRP, indicating that protection against circulating wild-type Hib had been generated. Successful induction of immunological memory occurred even when there was no measurable humoral anti-PRP response to the primary course. Tetanus-PRP conjugate vaccine can be used in combination with DTPa-HBV vaccine, when administered separately or as a single injection in the same syringe, in primary immunisation schedules at 3, 4 and 5 months of age.Type of Medium: Electronic ResourceURL: